Viewing StudyNCT00271167

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-05 @ 4:35 PM
Last Modification Date: 2024-10-26 @ 9:21 AM
Study NCT ID: NCT00271167
Status: TERMINATED
Last Update Posted: 2015-03-25
First Post: 2005-12-29
Brief Title: A Trial of INO-1001 in Patients Undergoing Heart Surgery That Involves Heart-lung Bypass
Sponsor: Inotek Pharmaceuticals Corporation
Organization: Inotek Pharmaceuticals Corporation
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Postoperative Complications
Heart Diseases
Keywords:
Name View
Cardiac valve replacement View
Cardiac surgery View
PARP inhibitor View
PARP inhibition View
Bypass surgery View
CPB surgery View
Cardiopulmonary bypass View
Coronary revascularization View